MA42679A - Dérivés de pyrrolidin-2-one annelés antibactériens - Google Patents

Dérivés de pyrrolidin-2-one annelés antibactériens

Info

Publication number
MA42679A
MA42679A MA042679A MA42679A MA42679A MA 42679 A MA42679 A MA 42679A MA 042679 A MA042679 A MA 042679A MA 42679 A MA42679 A MA 42679A MA 42679 A MA42679 A MA 42679A
Authority
MA
Morocco
Prior art keywords
ringed
pyrrolidin
antibacterial
derivatives
ringed pyrrolidin
Prior art date
Application number
MA042679A
Other languages
English (en)
Inventor
Philippe Panchaud
Christine Schmitt
Jean-Philippe Surivet
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of MA42679A publication Critical patent/MA42679A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
MA042679A 2015-08-28 2016-08-26 Dérivés de pyrrolidin-2-one annelés antibactériens MA42679A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP2015069757 2015-08-28

Publications (1)

Publication Number Publication Date
MA42679A true MA42679A (fr) 2018-07-04

Family

ID=56801557

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042679A MA42679A (fr) 2015-08-28 2016-08-26 Dérivés de pyrrolidin-2-one annelés antibactériens

Country Status (13)

Country Link
US (1) US20190031676A1 (fr)
EP (1) EP3341378A1 (fr)
JP (1) JP2018531902A (fr)
KR (1) KR20180041231A (fr)
CN (1) CN107922433A (fr)
AR (1) AR105839A1 (fr)
AU (1) AU2016314963A1 (fr)
CA (1) CA2991281A1 (fr)
EA (1) EA201890600A1 (fr)
MA (1) MA42679A (fr)
MX (1) MX2018002479A (fr)
TW (1) TW201718484A (fr)
WO (1) WO2017036968A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
WO2019086452A1 (fr) 2017-10-31 2019-05-09 Idorsia Pharmaceuticals Ltd Composés hétéroaromatiques antibactériens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR097617A1 (es) * 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
EA030730B1 (ru) * 2013-12-19 2018-09-28 Идорсиа Фармасьютиклз Лтд Антибактериальные производные 1h-индазола и 1h-индола
AR099612A1 (es) * 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
CA2948077A1 (fr) * 2014-05-16 2015-11-19 Actelion Pharmaceuticals Ltd Derives antibacteriens de quinazoline-4(3h)-one

Also Published As

Publication number Publication date
JP2018531902A (ja) 2018-11-01
AR105839A1 (es) 2017-11-15
MX2018002479A (es) 2018-06-15
TW201718484A (zh) 2017-06-01
EP3341378A1 (fr) 2018-07-04
CN107922433A (zh) 2018-04-17
KR20180041231A (ko) 2018-04-23
AU2016314963A1 (en) 2018-04-19
WO2017036968A1 (fr) 2017-03-09
CA2991281A1 (fr) 2017-03-09
US20190031676A1 (en) 2019-01-31
EA201890600A1 (ru) 2018-09-28

Similar Documents

Publication Publication Date Title
EP3690038A4 (fr) Conjugué anticorps-dérivé de pyrrolobenzodiazépine
EP3717479C0 (fr) Dérivés de thiazole microbiocides
PT3687999T (pt) Derivados de rapamicina
DK3316969T3 (da) Antibakterielle forbindelser
EP3677802A4 (fr) Pièce de glissement
MA54254A (fr) Dérivés de benzodiazépine cytotoxique
EP3334736C0 (fr) Dérivés hétérobicycliques microbiocides
EP3299684A4 (fr) Élément de coulissement
MA50657A (fr) Formulations de niraparib
MA41898A (fr) Dérivés de quinazolinone bicyclique
EP3457851A4 (fr) Dérivés de sobétirome
MA39822A (fr) Dérivés de pyrimidine bicycle
EP3315832A4 (fr) Élément de glissement
PT4039675T (pt) Compostos de fenil-2-hidroxi-acetilamino-2-metil-fenilo
EP3443043A4 (fr) Compositions de prétraitement
EP3430073A4 (fr) Composition de polyaryléthercétone
EP3309163A4 (fr) Dérivé de dihydropyrrolopyrazole substitué
EP3458041A4 (fr) Compositions antibactériennes
EP3333163A4 (fr) Dérivé de guanidine substitué
EP3554637A4 (fr) Dérivés de spiropipéridine
MA43397A (fr) Pyroglutamate de vortioxetine
EP3371163A4 (fr) Dérivés de pyrrolidine
MA50068A (fr) Formulations de copanlisib
MA44018A (fr) Dérivés de tétrahydroisoquinoline
EP3532269A4 (fr) Compositions de prétraitement